Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. The metric has seen a significant loss of -42.33% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -1.09%. Over the past 30 days, the price of RLAY has leaped by -15.67%. And in the last five days, it has surged by 2.25%.
Relay Therapeutics Inc experienced a rather shaky stock market performance. The highest value in the past year was recorded at $13.32 on 07/12/23 and the lowest value was $5.78 on 04/24/24.
52-week price history of RLAY Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Relay Therapeutics Inc’s current trading price is -52.33% away from its 52-week high, while its distance from the 52-week low is 9.86%. The stock’s price range during this period has varied between$5.78 and $13.32. The Relay Therapeutics Inc’s shares, which operate in the Healthcare, saw a trading volume of around 1.71 million for the day, a figure considerably higher than their average daily volume of 1.18 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Relay Therapeutics Inc (RLAY) has experienced a quarterly decline of -35.53% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 832.99M and boasts a workforce of 323 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 9.26, with a change in price of -1.71. Similarly, Relay Therapeutics Inc recorded 1,149,257 in trading volume during the last 100 days, posting a change of -21.22%.
RLAY’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for RLAY stands at 0.07. Similarly, the long-term debt-to-equity ratio is also 0.06.
RLAY Stock Stochastic Average
As of today, Relay Therapeutics Inc’s raw stochastic average for the last 50 days stands at 11.90%. This is a decline compared to the raw stochastic average of the previous 20 days, which was noted at 23.81%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 11.58% and 6.86%, respectively.
